Vicki DeArmon launched Foghorn Press and Sibylline Press, and has now written an “almost true” memoir of San Francisco’s ...

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

As the founder of a small publishing company in 1980s San Francisco, Vicki DeArmon recruited authors, negotiated contracts and persuaded stores to stock her books. Almost always, she said recently, ...

Though the neighborhood is normally relatively peaceful, Mainville said the malfunctioning foghorn at the end of the jetty is testing his nerves. “Over and over and over,” he said.

A malfunctioning foghorn has been blaring every 30 seconds off the coast of a Narragansett, Rhode Island, beach for the last few weeks. Narragansett residents spoke to NBC 10 about the relentless ...

March 06, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting ...

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have earned a consensus rating of “Buy” from the six ...

Foghorn Therapeutics Inc. announced continued enrollment in its Phase 1 trial for FHD-909, a first-in-class oral selective SMARCA2 inhibitor targeting SMARCA4 mutated cancers, particularly non ...

Y’all know as much about him as you do Foghorn Leghorn. Zelensky fills the void left by the demise of mid-day soap operas. He is the escape from reality that allows many to cope with the ...